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Abstract
Introduction: We set a goal to reduce the incidence rate of catheter-related bloodstream infections to rate of
<1 per 1,000 central line days in a two-year period.
Methods: This is an observational cohort study with historical controls in a 25-bed intensive care unit at a tertiary
academic hospital. All patients admitted to the unit from January 2008 to December 2011 (31,931 patient days)
were included. A multidisciplinary team consisting of hospital epidemiologist/infectious diseases physician, infection
preventionist, unit physician and nursing leadership was convened. Interventions included: central line insertion
checklist, demonstration of competencies for line maintenance and access, daily line necessity checklist, and quality
rounds by nursing leadership, heightened staff accountability, follow-up surveillance by epidemiology with timely
unit feedback and case reviews, and identification of noncompliance with evidence-based guidelines. Molecular
epidemiologic investigation of a cluster of vancomycin-resistant Enterococcus faecium (VRE) was undertaken
resulting in staff education for proper acquisition of blood cultures, environmental decontamination and daily
chlorhexidine gluconate (CHG) bathing for patients.
Results: Center for Disease Control/National Health Safety Network (CDC/NHSN) definition was used to measure
central line-associated bloodstream infection (CLA-BSI) rates during the following time periods: baseline (January
2008 to December 2009), intervention year (IY) 1 (January to December 2010), and IY 2 (January to December
2011). Infection rates were as follows: baseline: 2.65 infections per 1,000 catheter days; IY1: 1.97 per 1,000 catheter
days; the incidence rate ratio (IRR) was 0.74 (95% CI = 0.37 to 1.65, P = 0.398); residual seven CLA-BSIs during IY1
were VRE faecium blood cultures positive from central line alone in the setting of findings explicable by
noninfectious conditions. Following staff education, environmental decontamination and CHG bathing (IY2): 0.53
per 1,000 catheter days; the IRR was 0.20 (95% CI = 0.06 to 0.65, P = 0.008) with 80% reduction compared to the
baseline. Over the two-year intervention period, the overall rate decreased by 53% to 1.24 per 1,000 catheter-days
(IRR of 0.47 (95% CI = 0.25 to 0.88, P = 0.019) with zero CLA-BSI for a total of 15 months.
Conclusions: Residual CLA-BSIs, despite strict adherence to central line bundle, may be related to blood culture
contamination categorized as CLA-BSIs per CDC/NHSN definition. Efforts to reduce residual CLA-BSIs require a
strategic multidisciplinary team approach focused on epidemiologic investigations of practitioner- or unit-specific
etiologies.
* Correspondence: madhuri.sopirala@uchealth.com
3Division of Infectious Diseases, Department of Internal Medicine,
Department of Clinical Epidemiology, Ohio State University Wexner Medical
Center, 410 West 10th Ave, Columbus, OH, 43210, USA
Full list of author information is available at the end of the article
Exline et al. Critical Care 2013, 17:R41
http://ccforum.com/content/17/2/R41
© 2013 Exline et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Introduction
Healthcare-associated infections (HAI) are a significant
cause of morbidity and mortality for hospitalized
patients accounting for approximately 100,000 deaths
yearly in the United States [1]. Though intensive care
unit (ICU) beds make up the minority of hospital beds
nationwide, they account for the highest burden of
nosocomial infections [2]. Specifically, in the ICU, cen-
tral line-associated bloodstream infections (CLA-BSI)
account for much of the excess morbidity, health cost
expenditures, and mortality associated with nosocomial
infections [3-6].
The risk of developing a CLA-BSI depends on a vari-
ety of factors such as the duration of catheterization,
location of catheter, and type of ICU to which a patient
is admitted [4,5,7]. Evidence-based interventions effec-
tive in combating CLA-BSIs include: using chlorhexidine
skin preparation and maximal sterile barriers (MSB)
during insertion of central venous catheters (CVC), use
of checklists for insertion, using the subclavian or inter-
nal jugular vein instead of the femoral vein, and daily
review of line necessity [5-13].
These techniques have been validated in the literature
and put together in a ‘bundle’, which was installed by
the Institute for Healthcare Improvement (IHI) to help
providers deliver more consistent care [14-18]. However,
many of these studies have focused primarily on the
insertion of the central line [15,17-19] rather than
ongoing line maintenance. Other studies using compli-
ance coupled with adherence to safe line maintenance
standards and prompt removal, despite improvement in
CLA-BSI rates, have not necessarily documented rates
below the National Health Safety Network (NHSN)
benchmarks for CLA-BSI and certainly continue to
show rates of CLA-BSI above the ultimate goal of ‘near-
zero’ [15,16]. There have been suggestions that the high
sensitivity of the CLA-BSI surveillance definition by the
Center for Disease Control (CDC)/National Health
Safety Network (NHSN) leads to categorization of posi-
tive blood cultures as CLA-BSI when they may not actu-
ally be related to infections, rather contamination [20].
Some authors have made suggestions that zero CLA-BSI
may not be realistic at all [21]. Regardless of the cause
of these positive blood cultures, they have a potential to
lead to increased antibiotic use, removal of catheters
with placement of new catheters and even increased
hospital length of stay.
We implemented a systematic team approach with
very aggressive interventions surrounding the IHI CLA-
BSI bundle resulting in marginal success toward the tar-
get of reducing infections to near-zero in our ICU.
However, our innovative approach toward implementing
these interventions allowed us to reexamine the central
line bundle efficacy and augment our process improve-
ment strategy with accessory interventions as our unit’s
journey progressed to a near-zero rate of CLA-BSI.
Materials and methods
Design overview
This was an observational cohort study that used histor-
ical controls. The project was deemed as quality
improvement by the Institutional Review Board of this
organization and need for research approval and
informed consent was waived.
Setting and participants
The study setting was a 25-bed medical ICU located in
1200-bed tertiary care academic hospital at the Ohio
State University Wexner Medical Center. All patients
admitted or transferred into the unit were included in
the intervention. The patient population did not include
surgical ICU patients. The nursing to patient ratio aver-
aged 1:1.5 and varied between 1:1 and 1:2 as patient
acuity mandated.
Routine surveillance for CLA-BSI
We measured CLA-BSI rates during the following time
periods: baseline (January 2008 to December 2009),
intervention year (IY) 1 (January to December 2010),
and intervention year 2 (January to December 2011). All
blood cultures obtained from patients admitted to the
ICU were reviewed by the infection preventionist and all
suspected CLA-BSI were confirmed by an epidemiolo-
gist/infectious diseases physician utilizing the definition
put forth by the CDC through the NHSN [22]. We
defined a central line as a catheter that ends in the
superior or inferior vena cava at or near the heart. Spe-
cific lines present in our population included peripher-
ally inserted central catheters (PICC), central venous
catheters (CVC), and pulmonary artery catheters (PA).
Arterial lines were not included in CLA-BSI surveillance
per NHSN definition. However, we have not noticed any
central arterial line infections during our routine surveil-
lance. Total patient days were calculated daily by num-
ber of patients on the ICU service census at midnight.
The presence of at least one central line in a patient
was counted as one catheter day in accordance with the
NHSN guidelines [22]. There were no changes to the
epidemiology staff during the intervention period, nor
were there any changes to the CLA-BSI definition uti-
lized over the course of the study.
Interdisciplinary team formation - December 2009
A multidisciplinary team that included an infectious dis-
eases physician and infection preventionist, ICU medical
directors (critical care physicians), nurse manager and
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clinical nurse specialists (CNS) was convened. Each indi-
vidual’s role in the performance improvement process
was clearly defined in the initial meetings.
Interventions related to central line bundle - January
2010
Several interventions focused on the central line inser-
tion bundle, dressing maintenance and line access prac-
tices were simultaneously introduced or reemphasized
to ICU physicians and nurses in January 2010. This
marked the beginning of the intervention period.
1. At the start of each rotation, education was rein-
forced to all house staff to use the Vascular Access
Selection Criteria to ensure proper selection of catheter
site with emphasis on internal jugular or subclavian pla-
cement [23]. This education was part of a refresher
course in the hospital simulation laboratory on line pla-
cement and sterile technique.
2. Lines in the ICU were placed by resident physicians,
critical care or nephrology fellows, critical care attending
physicians, or the hospital PICC insertion nursing team.
Ultrasound was used to place nonemergent central lines.
3. The continued need for a CVC was reviewed daily,
during interdisciplinary ICU rounds by the critical care
fellow as part of the daily goals checklist, with removal
of the catheter wherever possible [3-5]. In addition, the
critical care fellow and the CNS reviewed line necessity
during quality rounds that were conducted each
afternoon.
4. Nurses placed peripheral intravenous catheters with
ultrasound guidance wherever possible to avoid CVC
placement and to facilitate removal.
5. Removal within 24 hours of all CVCs placed emer-
gently, that is ‘code lines’ or any line placed without
maximum sterile barrier precautions (sterile gown, ster-
ile gloves, full-size sterile drape, face mask, cap, and
chlorhexidine skin preparation solution). A label was
used to identify these catheters as emergently placed
central lines.
6. CNS led mandatory demonstration session for dres-
sing change and proper line access on a manikin for all
nursing staff at the beginning of the study. During this
session, all nursing staff was assessed for competence in
their dressing change and line access techniques. Chlor-
hexidine gluconate (CHG) Tegaderm™ dressings were
used on all central lines from the beginning of IY1. Nur-
sing performance was evaluated annually by unit man-
agement staff as part of annual mandatory education.
7. A CVC insertion checklist, with all requirements to
comply with the sterile procedure for CVC placement,
was attached to all central line kits. All CVCs placed
were antimicrobial catheters. Nursing staff was
instructed to use the checklist at the time of line inser-
tion. All providers in the room were required to wear
sterile cap, mask, and gloves. Nurses were empowered
to stop procedures if sterile technique was not correctly
employed. Arterial lines were placed in a similar fashion
using full barrier precautions.
8. All CVC and PICC insertion trays were augmented
with components to comply with the central line bundle
including the use of chlorhexidine sponges for cleaning
the skin.
9. The infection preventionist gave feedback to the
unit on adherence to protocol based on the central line
dressing maintenance audits performed each month and
any CLA-BSI every week. These audits assessed compli-
ance with keeping the dressings clean, dry and intact. In
addition, staff nurses were encouraged to practice
proper line access techniques on a monthly basis by the
nurse manager via emails and during staff meetings.
Timely feedback on CLA-BSI occurrence and sentinel
event investigation on CLA-BSI at the unit level - January
2010
Clinical Epidemiology provided weekly feedback on
CLA-BSI occurrence to the unit leadership that included
the ICU medical directors, CNS and nurse manager.
The CNS responsible for each investigation was able to
evaluate practitioner variation, nursing variation, CVC
access and blood culture collection techniques, and ana-
tomical CVC site of placement among other factors that
may have contributed to each CLA-BSI. The nurse man-
ager and medical directors shared the results of the
investigation with the unit’s nursing and medical staff,
respectively.
Positive reinforcement strategy - June 2010
We engaged hospital leadership to establish milestones
for CLA-BSI avoidance (100, 200, and 365 days) and
provide incentives upon achieving the milestones to sus-
tain CLA-BSI improvement. These included coat pins
indicating the days without a CLA-BSI and recognition
breakfasts for the unit staff.
Clinical epidemiologic investigation - November 2010
We conducted an epidemiologic investigation at the end
of IY1 when, despite a modest improvement in CLA-
BSI rates, there was a continued CLA-BSI burden in the
face of implementation of and compliance with aggres-
sive measures toward the CVC bundle and line mainte-
nance practices. We investigated the types of organisms
causing CLA-BSIs and the location of CLA-BSI patients
within the ICU to evaluate for clustering of infections.
Upon noting a surge and clustering of vancomycin-resis-
tant Enterococcus (VRE) faecium CLA-BSIs from certain
ICU rooms, Epidemiology performed environmental cul-
tures of 42 high-touch surfaces (HTS) within the rooms
where patients with VRE faecium CLA-BSI were
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identified. HTS cultured included bed rails, bedside
tabletops, and keyboards, call buttons, supply cart han-
dles and television remote controls.
Molecular epidemiologic investigation - December 2010
Based on the results of the clinical epidemiologic inves-
tigation, a molecular epidemiologic investigation was
conducted. Molecular typing of VRE faecium isolated
from blood cultures and patients’ environment was per-
formed using repetitive extragenic palindromic
sequence-based polymerase chain reaction (rep-PCR)
DiversiLab kits (bioMérieux, Durham, NC, USA) follow-
ing the Diversilab™ Enterococcus kit package insert and
previously described methods [24-26]. An ATCC™ E.
faecalis 51299 strain was used as control along with
another E. faecium control strain obtained from a
patient’s blood culture from a different area in the hos-
pital. The modified Kullback-Leibler distance method
was used to create a pairwise percent similarity matrix,
and a dendrogram was generated using the unweighted
pair group method of arithmetic averages. Isolates sharing
greater than 97% similarity and/or indistinguishable (no
band difference) were grouped for further analysis. The
graph overlay feature was utilized to observe small differ-
ences between isolates that were otherwise not apparent
on virtual gel images. Each new rep-PCR pattern identified
was based on one peak difference and was assigned a
sequential numeric classification based on the overlay.
VRE organisms were considered similar if they had a one-
peak difference.
Environmental decontamination and nursing staff
education - end of December 2010
Hospital policy already specified that all patients with
VRE required contact isolation including a gown and
gloves for anyone entering the room. Based on the
results of the above investigation, in addition to conti-
nuation of contact isolation protocols an intensive term-
inal cleaning of all ICU rooms was conducted. Each pod
of the ICU was emptied for a day at a time by moving
patients into a different pod to facilitate this cleaning.
The walls, floors and all surfaces and equipment in the
rooms were spot cleaned and wiped down with a disin-
fectant. Environmental Services (EVS) personnel created
a dedicated cleaning team that was specifically trained
to clean the ICU rooms. Nursing staff was educated
about proper technique for obtaining blood cultures
by the clinical nurse specialists to reinforce their
knowledge.
Follow-up environmental culturing - March 2011
We repeated environmental culturing to document
decontamination of VRE following deep cleaning of ICU
rooms. Over 200 HTS from all ICU rooms were
cultured for VRE to assess for continued effectiveness of
cleaning by our EVS staff that were unaware of this
surveillance.
Chlorhexidine gluconate bathing - April 2011
We introduced CHG bathing of all patients in the ICU
in response to one VRE CLA-BSI that occurred three
months after environmental decontamination. This
intervention was introduced to reduce the potential
bacterial burden on patients [4]. Patients admitted to
the ICU underwent a CHG bath on admission and
daily with a diluted solution of 4% chlorhexidine glu-
conate in tap water based on previous studies show-
ing eradication of VRE and methicillin-resistant
Staphylococcus aureus (MRSA) colonization at this
dose [27,28].
Data collection
We measured CLA-BSI incidence per NHSN definition
[29] before (baseline period) and after (post-intervention
period) the implementation of the ‘line bundle’ and sub-
sequent process improvement methods. The quarterly
rate of infections was calculated as follows: (number of
CLA-BSIs/number of central line days) × 1,000 for each
three-month period. Quarterly rates were assigned to
one of four categories based on when the study inter-
vention was implemented: at baseline, during the early
post-intervention period (year 1), or late post-interven-
tion period (year 2). We also collected data on the num-
ber of temporary CVCs, including PICCs used in ICU
patients over the study years. Device utilization ratio
was calculated as follows in accordance with NHSN
guidelines: number of device or catheter days/number of
patient days [29]. Patient days were counted using the
daily ICU census at midnight.
Outcome measures and study hypotheses
Primary outcome measure was quarterly CLA-BSI rate
per 1,000 central line days. Secondary outcome mea-
sures were compliance with CVC insertion and dressing
maintenance practices. The primary study hypothesis
was that the CLA-BSI rate would be reduced by at least
50% after implementation of the study intervention as
compared to the baseline over a two-year intervention
period. We did not evaluate the relative effectiveness of
the separate components of the intervention.
Statistical analysis
As used in previous studies [5], and because CLA-BSIs
are rare events, a Poisson regression analysis was used
to generate an incidence rate ratio (IRR) compared with
baseline CLA-BSI rates (Stata software, version 10;
Statacorp, College Station, TX, USA).
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Results
CLA-BSI reduction
There were 2.65 infections per 1,000 catheter days (30
CLA-BSIs in 11,317 central line days) in the ICU in the
baseline period (Table 1). The net infection rate at the
end of the two-year intervention period decreased by
53% to 1.24 infections per 1,000 catheter days (14 CLA-
BSIs in 11,271 central line days) with IRR of 0.47 (95%
CI = 0.25 to 0.88, P = 0.019) (Table 1). During IY1, the
CLA-BSI rate was reduced to 1.97 per 1,000 catheter
days (11 CLA-BSIs in 5,589 central line days); the IRR
was 0.74 (95% CI = 0.37 to 1.65, P = 0.398). During IY2
(months 13 to 24 of the intervention), the CLA-BSI rate
further reduced to 0.53 per 1,000 catheter days (3 CLA-
BSI in 5,682 central line days); the IRR was 0.20 (95%
CI = 0.06 to 0.65, P = 0.008) with 80% reduction com-
pared to the baseline period. There were zero CLA-BSIs
for the last 10 months of the intervention period
included in the analysis (Figure 1) and with zero CLA-
BSIs for a total of 15 calendar months.
Compliance with insertion, dressing maintenance, and
line removal
Compliance with CVC insertion practices was high
based on the audits; compliance with CVC dressing
maintenance increased steadily and remained high at 80
to 100% during the intervention period assessments
(Figure 1). Despite a daily checklist to remind the team
of prompt removal of unnecessary CVCs, device utiliza-
tion ratio (central line days/patient days) did not signifi-
cantly change during the intervention (Table 2).
Clinical epidemiologic investigation
Seven out of eleven CLA-BSIs in 2010 were caused by
VRE faecium (Table 2). Four out of seven patients with
a VRE CLA-BSI were located in pod B; of the other
three patients, one was in pod A, one in pod C and one
in pod D (Figure 2). Out of the four patients with a
VRE CLA-BSI in pod B, two were located in one room
during different months; the other two were located in
another room during different months. Selective envir-
onmental culturing for VRE of HTS was performed
initially only in the rooms that harbored patients with a
VRE CLA-BSI in 2010. Out of 40 HTS sites cultured in
five patient rooms, 8/40 (20%) sites cultured positive for
VRE faecium. The HTS that tested positive were bed
rails (three cultures), supply cart handles (two cultures),
computer keyboard (one culture), call button (one cul-
ture), and bedside table (one culture). Following deep
environmental cleaning, all cultures were negative for
VRE from all previously positive VRE patient rooms.
Additional follow-up cultures of HTS in all ICU rooms
performed four months later did not reveal any positive
VRE.
Molecular epidemiologic investigation
The rep-PCR patterns of all VRE faecium isolates were
depicted to be in Patterns 1 (Key numbers 5, 6), Pattern
3 (Key numbers 1, 2, 7, 8, 9, 15, 16), Pattern 5 (Key
numbers 3, 4, 13, 14), Pattern 9 (Key numbers 10, 11,
12, 17), Pattern 10 (Key number 18) and Pattern 11
(Key number 19). Based on the overlay, Pattern numbers
1, 3, 5 and 9 had a single band difference and were
related. Pattern numbers 10 and 11 were different from
Pattern numbers 1, 3, 5 and 9. The E. faecium control
strain obtained from a blood culture from a patient in a
different area (Pattern 9; Key number 17) had a one-
band difference from Patterns 1, 3, and 5. It was related
to the patient and environmental samples under investi-
gation. Control VRE faecalis strain ATCC™ 51299 (Pat-
tern number 11; Key number 19) was unrelated to the
patient and environmental samples under investigation
(Figure 3).
Sentinel event investigation of residual CLA-BSI
All seven residual CLA-BSIs were caused by VRE fae-
cium. All VRE were cultured from one bottle from a
CVC with one or more negative culture bottles from
simultaneous peripheral blood cultures in all patients.
Scenarios where blood cultures were obtained included:
in response to hypotension caused by gastrointestinal
bleed in two patients, pulseless electrical activity (PEA)
in two patients (one after a radical neck dissection, one
after transjugular intrahepatic portosystemic shunt
(TIPS) procedure), one temperature recording of 100.8
in a patient with deep venous thrombosis (DVT), in
Table 1 CLA-BSI incidence rate/1000 patient days, incidence rate ratio (IRR) in the post-intervention period compared
to baseline period.
Surveillance period Number of CLA-BSI Central line days CLA-BSI rate/1000
central line days
IRR (95% CI) Percentage reduction* P value
Baseline (two-year period) 30 11,317 2.65 NA NA NA
Post-intervention year 1 11 5,589 1.97 0.74 (0.37-1.65) 26% 0.398
Post-intervention year 2 3 5,682 0.53 0.20 (0.06-0.65) 80% (35%-94%) 0.008
Post-intervention total 14 11,271 1.24 0.47 (0.25-0.88) 53% (12%-75%) 0.019
*Compared to baseline period. CI, confidence interval; CLA-BSI, central line-associated bloodstream infections; NA, not applicable.
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response to leukocytosis in a patient who was afebrile
and was treated with corticosteroids, and in response to
leukocytosis in a patient with acute coronary syndrome.
All seven patients had their catheters removed. Three
patients died within three days of diagnosis of bactere-
mia secondary to their presenting diagnosis with none
of the deaths attributed to the CLA-BSI. Four patients
were treated for bacteremia for 14 days.
Discussion
CLA-BSIs continue to be a challenge in healthcare deliv-
ery, especially in the ICU, where nearly 50% of patients
will have a CVC inserted at some point in their care
[30]. CLA-BSIs are responsible for significant morbidity
resulting in extended hospitalizations, hospital costs
accounting for a loss of up to $26,000 per CLA-BSI
[31], and increased mortality accounting for approxi-
mately 100,000 deaths a year [1]. Though multiple
investigators have reported interventions surrounding
the central line bundle to successfully reduce the burden
of CLA-BSIs in their units, few have reported the results
of continued process improvements and secondary
interventions that can be utilized when, as is often the
case, compliance with the CVC bundle alone has not
resulted in a significant reduction in these infections.
Our unit’s culture in the baseline period likely mir-
rored what may be the standard culture in many institu-
tions. Physicians and nurses were aware of the dangers
of CLA-BSIs and educated on the expectation for strict
adherence to sterile techniques for insertion and access
of central lines. Physicians were expected to utilize full-
barrier precautions and ultrasound guidance for CVC
insertion. However, as with many academic institutions,
there was a high turnover of new trainees into the envir-
onment making a sustained cultural change more diffi-
cult. Into this environment, our epidemiology team
championed a systematic team-oriented approach to
optimally reduce CLA-BSI to a near-zero rate. The
implementation of a central line ‘bundle’ resulted in
excellent compliance with sterile insertion techniques
and substantial improvements in central line dressing
care. However, despite improved compliance with the
bundle, our initial efforts resulted in only a modest
improvement of our CLA-BSI rate and the use of CHG
Figure 1 Central line-associated bloodstream infections, compliance with central line insertion and dressing maintenance during the
study period. NHSN, National Health Safety Network.
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Jan-08 1 550 1.82 700 0.79 VRE faecium
Feb-08 2 547 3.66 675 0.81 Acinetobacter baumannii
Methicillin-resistant Staphylococcus
epidermidis




Apr-08 1 470 2.13 661 0.71 Group B Streptococcus agalactiae
May-08 1 468 2.14 668 0.70 Methicillin-resistant Staphylococcus
epidermidis
Jun-08 1 478 2.09 629 0.76 Enterobacter cloacae
Jul-08 0 351 0.00 626 0.56
Aug-08 1 340 2.94 683 0.50 Klebsiella oxytoca
Sep-08 0 360 0.00 649 0.55
Oct-08 0 510 0.00 691 0.74
Nov-08 1 518 1.93 696 0.74 Pseudomonas aeruginosa
Dec-08 2 514 3.89 699 0.74 Klebsiella pneumoniae
Methicillin-resistant Staphylococcus
epidermidis
Jan-09 2 461 4.34 700 0.66 Prevotella buccae and Achromobacter
xylosoxidans
Feb-09 1 474 2.11 634 0.75 Candida glabrata
Mar-09 4 568 7.04 721 0.79 Pseudomonas fluorescans,
Peptostreptococcus, VRE faecium
Apr-09 0 417 0.00 639 0.65
May-09 1 394 2.54 644 0.61 Candida albicans, VRE faecium
Jun-09 0 358 0.00 626 0.57
Jul-09 3 389 7.71 673 0.58 Candida glabrata, VRE faecium, E.coli
Aug-09 2 513 3.90 684 0.75 Acinetobacter baumannii, VRE faecium
Sep-09 0 436 0.00 661 0.66
Oct-09 1 505 1.98 699 0.72 Pseudomonas aeruginosa
Nov-09 1 569 1.76 679 0.84 Klebsiella pneumoniae
Dec-09 2 565 3.54 728 0.78 Enterococcus faecalis, Acinetobacter
baumannii
Jan-10 0 468 0.00 678 0.69
Feb-10 0 411 0.00 626 0.66
Mar-10 2 457 4.38 623 0.73 VRE faecium, VRE faecium
Apr-10 2 386 5.18 565 0.68 Methicillin-resistant Staphylococcus
epidermidis, VRE faecium
May-10 0 480 0.00 615 0.78
Jun-10 2 479 4.18 612 0.78 Morganella morganii, Enterobacter cloacae
Jul-10 0 468 0.00 654 0.72
Aug-10 1 478 2.09 627 0.76 VRE faecium
Sep-10 0 423 0.00 626 0.68
Oct-10 2 534 3.75 711 0.75 VRE faecium, VRE faecium
Nov-10 2 532 3.76 679 0.78 VRE faecium, Methicillin- resistant
Staphylococcus epidermidis
Dec-10 0 473 0.00 620 0.76
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Table 2 Monthly CLA-BSI during the study period, device utilization ratio and organisms causing CLA-BSI in each
month. (Continued)
Jan-11 0 485 0.00 712 0.68
Feb-11 1 485 2.06 647 0.75 VRE faecium
Mar-11 2 535 3.74 709 0.75 VRE faecium, Enterococcus faecalis
Apr-11 0 501 0.00 641 0.78
May-11 0 461 0.00 677 0.68
Jun-11 0 448 0.00 621 0.72
Jul-11 0 351 0.00 655 0.54
Aug-11 0 454 0.00 690 0.66
Sep-11 0 543 0.00 705 0.77
Oct-11 0 473 0.00 677 0.70
Nov-11 0 473 0.00 653 0.72
Dec-11 0 473 0.00 704 0.67
CLA-BSI, central line-associated bloodstream infections.
Pod A Room Pod A Room Pod A Room Pod A Room Pod B Room Pod B Room Pod B Room
Pod B Room
Pod A Room Pod A Room Pod A Room Pod B Room
Pod A Pod B
Pod B Room
Pod C Room Pod C Room Pod C Room Pod D Room Pod D Room
Pod C Pod D
Pod D Room
Pod C Room Pod C Room Pod C Room Pod D Room Pod D Room
Pod D Room
Figure 2 Intensive care unit layout; four patients with VRE central line-associated bloodstream infection were located in two rooms of
pod B - two in one room and two in another room. One patient each was located in each of the other pods.
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Tegaderm™ dressings may or may not have contributed
to this modest improvement; we were still far from our
goal.
Our innovative team approach engaged hospital epide-
miologists and clinicians with weekly CLA-BSI surveil-
lance followed by immediate, unit-level, root cause
analysis, which facilitated feedback to clinicians in a
timely fashion when they still remembered the circum-
stances surrounding the infection. In the majority of our
CLA-BSIs in IY1 we suspected potential blood culture
contamination with VRE coupled with clinical deteriora-
tion from a noninfectious etiology as a likely cause of
persistence of CLA-BSIs despite our compliance with
bundle elements. Our interdisciplinary approach with
infection prevention experts, critical care physicians and
nursing staff working as one team facilitated an investi-
gation that identified geographic clustering of VRE cases
in our ICU. As VRE can cause both monoclonal and
polyclonal outbreaks [32-35], we performed environ-
mental cultures coupled with a molecular epidemiologic
investigation based on our finding of geographic cluster-
ing and our suspicion of blood culture contamination.
This documented environmental contamination with
VRE and demonstrated the genetic similarity between
environmental VRE and the VRE associated with these
CLA-BSIs. We then implemented a very aggressive
intervention of cleaning our ICU by systematically emp-
tying one ICU pod at a time and engaging our Environ-
mental Services team in our process improvement
strategy. This investigation also recognized deficiencies
in the structure of our environmental cleaning plan and
identified the need to have more highly trained cleaning
staff that was dedicated to an ICU. As a result, we have
now employed environmental cleaning teams that are
dedicated to ICUs and are trained to clean around ICU
equipment in our institution. Studies have shown elimi-
nation of VRE colonization events by meticulous atten-
tion to environmental cleaning [36,37], but very few
have utilized environmental decontamination as an
intervention to achieve a reduction in VRE CLA-BSIs.
We observed a decline in our VRE CLA-BSI upon
implementation of meticulous environmental cleaning.
We chose not to conduct admission and/or weekly sur-
veillance cultures for VRE colonization followed by con-
tact isolation as an intervention as it is an expensive
strategy. Instead, based on our investigation and find-
ings, we focused on improving environmental cleaning
and reducing potential bacterial burden on our ICU
patients [4,27,28].
Based on our experience, there can be an underlying
cause for reminiscent CLA-BSIs after implementation of
a process improvement project emphasizing bundle
compliance. How to deal with these residual infections
is not frequently reported in the literature. There are
many potential interventions including patient cohort-
ing, purpose-made catheter sterilizing devices, dedicated
line teams or, as in our case, environmental decontami-
nation to name a few. Deciding which intervention to
use next could be difficult and using all or some inter-
ventions randomly can be costly. We suggest that unit
leaders should investigate the root cause of their resi-
dual infections rather than implementing further mea-
sures piecemeal.
This work demonstrates the success of this positive
approach to the issue of CLA-BSIs, investigating the
underlying cause of reminiscent CLA-BSI thereby sus-
taining CLA-BSI reduction. We have demonstrated that
with an iterative team approach and by eliminating
underlying causes of residual CLA-BSI and basing our
approach on internal evidence for the need for further
interventions, CLA-BSI reduction is possible and sus-
tainable. Our efforts to reduce CLA-BSI incidence
demonstrate a synchronized model for multidisciplinary
teams, which included a hospital epidemiologist and
administrative leaders to increase compliance with bun-
dle elements and to decrease blood culture contamina-
tion. We engaged hospital leadership to establish
milestones and recognize the unit at the institutional
level upon milestone achievement. This strategy resulted
in a positive effect on morale, and facilitated staff com-
pliance with the new standards of care. At the same
time, it promoted the culture of safety: no one wanted
to be the practitioner that started the clock back to zero
days since the last CLA-BSI. We believe that these two
strategies played an important role in sustaining our
success with CLA-BSI reduction.
We observed a stability of the device utilization ratio,
which may be due to the fact that a patient with multi-
ple lines; for example, a triple-lumen CVC, and dialysis
catheter counts as one line day, even with discontinua-
tion of one of the lines the patient would still count as a
central line day. Thus the device utilization ratio may
underrepresent how many lines were being removed
even with aggressive removal based on a daily goals
checklist. While the burden and exposure may be
reduced, the device utilization ratio will not account for
this. This may argue for counting the number of lines
or even lumens for a lumen/patient/day count. Unfortu-
nately, this may be unfeasible in most settings leading to
inaccurate counts. However, improved line day counts
might be possible in future studies as electronic medical
record tracking of vascular access days in ICUs
increases.
Our experience also validates the existent concerns
that all CLA-BSI may not be preventable given the high
sensitivity and low specificity of CDC/NHSN definition,
as some of these positive blood cultures with significant
pathogens may be related to contamination or catheter
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colonization [20]. This may especially be true in units
colonized with resistant bacteria such as VRE or MRSA.
Eventually, these units may be penalized financially if, as
planned, healthcare providers in the United States
receive only limited reimbursement from the Centers
for Medicare and Medicaid Services (CMS) for any
CLA-BSI acquired in the hospital, since this is now
accepted as ‘preventable’ [21]. An acceptable compro-
mise may envision CMS accounting the reasons why the
reminiscent CLA-BSIs were not preventable on a case-
by-case basis (for example, an ‘infection’ per definition
may not be an infection at all or the ‘infection’ may be a
secondary bloodstream infection with another potential
primary site) instead of basing reimbursement merely
on CLA-BSI rate per institution.
Our study does have several limitations. First, we stu-
died one particular ICU population with a homogeneous
group of nurses and house staff. Thus, our results may
not be extrapolated to surgical, cardiac, or other ICU
populations. However, the principle of our process is
the continuous reporting of CLA-BSIs and refinement
of unit-specific interventions, which should be
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reproducible in other ICU populations. Second, we did
not continuously monitor central line insertion and
dressing maintenance throughout the intervention per-
iod. Even at baseline, the compliance with sterile techni-
que for insertion was extremely high and in addition,
these audits were labor intensive and we felt that inter-
mittent auditing was an acceptable alternative to contin-
uous audits once compliance with the sterile line
insertion techniques and dressing maintenance had been
achieved. In addition to intermittent audits, we continue
to conduct educational sessions with periodic (yearly)
reinforcement of education related to central line main-
tenance and access. Our CNSs continued to investigate
any new CLA-BSIs including assessment of line access
practices and insertion technique. In addition, house
staff trainees are given a half-day training session in our
simulation laboratory emphasizing central line place-
ment prior to each rotation in the ICU. Third, we only
cultured the ICU rooms where patients were diagnosed
with VRE CLA-BSI during the first round of environ-
mental culturing. However, we felt the high prevalence
of VRE on HTS in the rooms cultured justified the deep
cleaning of every room in the unit. In addition, we cul-
tured all HTS in all ICU rooms during our follow-up
environmental culturing to document decontamination
of the rooms post environmental cleaning and to assess
continued effective cleaning by our environmental staff.
Fourth, we monitored hand hygiene upon entry and exit
of the rooms through audits performed by the unit staff,
which showed very high compliance of greater than 90%
during early months of the study, but we did not moni-
tor whether staff cleaned hands prior to accessing cen-
tral lines. Doing such audits anonymously for accurate
data gathering would be a challenge but we believe that
with increased awareness of CLA-BSI prevention, this
practice improved over time during this study. Last, we
did not evaluate the relative effectiveness of the separate
components of the intervention related to central line
bundle. However, our goal was to attain maximal
improvement of patient safety in our ICU; this quality
improvement initiative was designed to optimize the use
of well-documented best practices and offered the great-
est probability of reducing CLA-BSI incidence. We saw
a stepwise decline in CLA-BSIs as we strategically intro-
duced accessory interventions beyond the central line
bundle. It remains unknown whether implementation of
CHG bathing alone or environmental cleaning alone
(given enough time) in the absence of the other would
have eliminated reminiscent sporadic CLA-BSI in our
ICU. However, we believe that deep environmental
cleaning along with correction of deficiencies in the
daily environmental cleaning for ICUs was necessary to
reduce bacterial burden in the environment surrounding
the patients in our ICU. We saw a decline in VRE CLA-
BSIs after this intervention but extended the decontami-
nation approach to patients with another occurrence of
VRE CLA-BSI since our follow-up cultures did not
reveal VRE on multiple HTS. Our approach demon-
strates our zero tolerance for CLA-BSI occurrence in
our ICU. We also validated the currently existing
thoughts about the high sensitivity and poor specificity
of CDC/NHSN definition for CLA-BSI. We showed that
multidisciplinary efforts toward clinical epidemiologic
investigation could actually lead to a near-zero rate even
in a complex ICU in a tertiary care hospital such as
ours despite these concerns.
It may be argued, in light of the fact that the majority
of our residual CLA-BSIs were suspected to be con-
taminants, that our improvement comes at a significant
resource cost and that we implemented aggressive
interventions to try to curtail nonexistent infections in
the setting of contamination; however, we submit that
these were reasonable interventions since we suspected
central line contamination which, in the setting of high
environmental burden, reflects the risk of impending
invasive infections unless action is taken. In addition, it
is difficult for physicians to choose not to treat a
patient who has a positive blood culture with a signifi-
cant pathogen. Retrospectively, we suspected that the
majority of these cultures were contaminants; however,
the treating team presented with the culture results on
critically ill patients in real time had to treat the culture
as a real result. Thus the elimination of these poten-
tially erroneous CLA-BSIs has the added effect of redu-
cing unnecessary antibiotic use. Unnecessary antibiotic
use, however, can lead to increased hospital length of
stay among other complications thus making it impor-
tant to eliminate blood culture contamination via both
compliance with line insertion bundle and environmen-
tal decontamination. We encouraged clinicians to avoid
drawing blood cultures from the existing catheters at
the same time as we instituted these interventions.
However, we saw improvement in CLA-BSI before
there was a change in this behavior. We are slowly see-
ing a change in this behavior and are continuing to
work on changing the culture of drawing blood cultures
from existing CVCs. We felt that it was important to
address the recognized deficiencies in the structure of
our environmental cleaning plan and address the envir-
onmental contamination as soon as we identified the
problem.
Conclusions
In conclusion, strict adherence to the central line bundle
is essential to prevention of CLA-BSIs, but may not
completely eliminate these infections as blood culture
contamination contributes to CLA-BSIs that are
detected by CDC/NHSN surveillance definition. Efforts
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to further reduce residual CLA-BSIs require a strategic
multidisciplinary team approach focused on epidemiolo-
gic investigations of practitioner or unit-specific etiolo-
gies. Continuous process improvement can then be
targeted at local factors contributing to a CLA-BSI, such
as environmental contamination in our case, with evi-
dence-based interventions. Sustained reduction of CLA-
BSIs requires longitudinal support of hospital and unit
leadership to continue to improve the care of our most
vulnerable ICU patients.
Key messages
Our study methods and findings include:
• Use of a multidisciplinary team including Clinical
Epidemiology for root cause investigations.
• With reeducation and reemphasis on the central line
bundle we achieved modest reductions in our rate of
central line-associated bloodstream infections (CLA-
BSIs) during our first year.
• During the second year, we utilized a root cause
analysis approach to investigating our CLA-BSIs leading
to the discovery of environmental contamination and
eradication of CLA-BSIs with patient chlorhexidine
bathing and deep environmental cleaning.
• Use of PCR techniques to confirm environmental
contamination as the source of CLA-BSIs.
• Discussion of the CDC definition of CLA-BSI that
includes inclusion of potentially contaminated line cul-
tures in the calculated rate of CLA-BSIs for the unit.
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